DENALI THERAPEUTICS INC.

549300ZTQ2HO18L3Q830

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: October 13, 2013

Address

Country: United States
Legal address: C/O THE CORPORATION TRUST COMPANY19801 WILMINGTONUnited States (US-DE)
Head office: 161 OYSTER POINT BLVD, 5TH FLOOR94080 South San FranciscoUnited States (US-CA)

Identifier

LEI: 549300ZTQ2HO18L3Q830
Registered: August 16, 2017 at 03:27 PM UTC
Last updated: February 16, 2024 at 01:30 PM UTC
Next renewal: February 16, 2024 at 12:00 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 5414857
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 5414857
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300ZTQ2HO18L3Q830This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search